UK Policy Paper – Collaboration on science and innovation
The UK has recently published a paper which outlines the UK’s objectives for a science and innovation agreement with the EU following Brexit.
The paper outlines a number of examples where the UK sees potential mutual benefit in a close working relationship between the UK and the EU, and invites discussion with the EU on how best to shape the future partnership in this area.
There are many examples of collaboration betwwen the UK and the EU including work in
- Medical Research
- Collaboration with European partners through international (non-EU) organisations such as
- European Organisation for Nuclear Research (CERN)
- European Space Agency (ESA)
- European Bioinformatics Institute (EBI)
This intergovernmental network helps mostly small and medium sized enterprises (SMEs) across Europe and around the world to collaborate on R&D across borders to bring innovative ideas to market. EUREKA has 41 European members and four non-European associate members.
This is the European platform for collaboration on particle physics and the fundamental laws of nature. The UK was a founding member of CERN, which now includes membership from 22 countries, including Israel.
This agency is an international organisation with 22 Member States from across Europe. Canada also sits on the governing council and participates in some projects under a cooperation agreement.
This is one of six institutes of the European Molecular Biology Laboratory (EMBL). EMBL, which comprises 23 EU Member States, two associate members, and five additional funding partners, focuses on molecular biology research and services.
- Collaboration through EU and European Atomic Energy Community (Euratom) programmes
The UK is looking to agree a far-reaching science and innovation agreement with the EU that establishes a framework for future collaboration and would welcome dialogue with the EU reflecting the joint interest in promoting continued close cooperation, for the benefit of both UK and European prosperity.